Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Rosner

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Statistics in Biopharmaceutical Research|June 4, 2020
Bayesian Methods in Regulatory ScienceGary L Rosner
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Bayesian approaches to evaluating doses of drugsGary L Rosner
Biometrics|March 2, 2005
Bayesian monitoring of clinical trials with failure-time endpointsGary L Rosner
Biometrics|April 7, 2020
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'HaganGary L Rosner, Peter Müller
Statistics in Medicine|March 19, 2019
A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidenceChenguang Wang, Gary L Rosner
Statistics in Medicine|July 13, 2006
A semi-parametric Bayesian approach to average bioequivalencePulak Ghosh, Gary L Rosner
Biometrical Journal. Biometrische Zeitschrift|February 7, 2025
A Bias-Corrected Bayesian Nonparametric Model for Combining Studies With Varying Quality in Meta-AnalysisPablo Emilio Verde, Gary L Rosner
Cancer Epidemiology|September 8, 2009
A projection of benefits due to fecal occult blood test for colorectal cancerDongfeng Wu, Diane Erwin, Gary L Rosner
Biometrics|January 13, 2006
MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screeningDongfeng Wu, Gary L Rosner, Lyle Broemeling
Biostatistics (Oxford, England)|October 13, 2006
Screening designs for drug developmentDavid Rossell, Peter Müller, Gary L Rosner
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Statistics in Biopharmaceutical Research|June 4, 2020
Bayesian Methods in Regulatory ScienceGary L Rosner
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Bayesian approaches to evaluating doses of drugsGary L Rosner
Biometrics|March 2, 2005
Bayesian monitoring of clinical trials with failure-time endpointsGary L Rosner
Biometrics|April 7, 2020
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'HaganGary L Rosner, Peter Müller
Statistics in Medicine|March 19, 2019
A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidenceChenguang Wang, Gary L Rosner
Statistics in Medicine|July 13, 2006
A semi-parametric Bayesian approach to average bioequivalencePulak Ghosh, Gary L Rosner
Biometrical Journal. Biometrische Zeitschrift|February 7, 2025
A Bias-Corrected Bayesian Nonparametric Model for Combining Studies With Varying Quality in Meta-AnalysisPablo Emilio Verde, Gary L Rosner
Cancer Epidemiology|September 8, 2009
A projection of benefits due to fecal occult blood test for colorectal cancerDongfeng Wu, Diane Erwin, Gary L Rosner
Biometrics|January 13, 2006
MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screeningDongfeng Wu, Gary L Rosner, Lyle Broemeling
Biostatistics (Oxford, England)|October 13, 2006
Screening designs for drug developmentDavid Rossell, Peter Müller, Gary L Rosner
Pageof 12